10.455  0.155 (1.5%)		01-30 15:51
Open: 10.43 High: 10.48 Volume: 5,081,363		Pre. Close: 10.3 Low: 10.37 Market Cap: 47,117(M)

Short term
Mid term
Targets	6-month :	12.34	1-year :	14.41
Resists	First :	10.56	Second :	12.34
Pivot price	10.13
Supports	First :	10.03	Second :	9.71
MAs	MA(5) :	10.37	MA(20) :	10.12
	MA(100) :	9.59	MA(250) :	9.93
MACD	MACD :	0.1	Signal :	0.1
%K %D	K(14,3) :	75.3	D(3) :	76.3
RSI	RSI(14): 63.3
52-week	High :	11.42	Low :	8.71

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ HLN ] has closed below upper band by 18.3%. Bollinger Bands are 39% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	10.39 - 10.45	10.45 - 10.5
Low:	10.1 - 10.18	10.18 - 10.24
Close:	10.19 - 10.31	10.31 - 10.4

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Fri, 30 Jan 2026
Haleon Tests New Sensitivity Toothpaste in China: What Investors Should Watch - TipRanks

Fri, 30 Jan 2026
Haleon share price rises in London as HLN stock turns to February results - TechStock²

Tue, 27 Jan 2026
Citi Remains a Buy on Haleon PLC (HLN) - The Globe and Mail

Tue, 27 Jan 2026
Haleon plc (HLN) Stock Analysis: A Promising 13.03% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

Sun, 25 Jan 2026
Kepler Capital Reaffirms Their Buy Rating on Haleon PLC (HLN) - The Globe and Mail

Fri, 23 Jan 2026
Barclays Upgrades Haleon plc - Depositary Receipt (HLN) - Nasdaq

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares Out	4,450 (M)
Shares Float	8,980 (M)
Held by Insiders	0 (%)
Held by Institutions	12.3 (%)
Shares Short	18,870 (K)
Shares Short P.Month	13,110 (K)

EPS	0.44
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	2.35
Profit Margin	13.8 %
Operating Margin	22.2 %
Return on Assets (ttm)	4.6 %
Return on Equity (ttm)	9.3 %
Qtrly Rev. Growth	-1.3 %
Gross Profit (p.s.)	1.57
Sales Per Share	2.47
EBITDA (p.s.)	0.59
Qtrly Earnings Growth	34.7 %
Operating Cash Flow	2,490 (M)
Levered Free Cash Flow	1,920 (M)

PE Ratio	23.25
PEG Ratio	0
Price to Book value	4.43
Price to Sales	4.22
Price to Cash Flow	18.7

Dividend	0.05
Forward Dividend	0
Dividend Yield	0.5%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.